Stroke Trial, Recruiting NCT07327593 Sponsor: Neuron, Spain Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07327593
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Healthy participants:

  • Adults aged 18 or older.
  • People with no neurological damage.
  • People with no medical conditions that could interfere with the test.

Post-stroke participants:

  • Adults aged 18 or older.
  • People who have had an ischemic or hemorrhagic stroke (a stroke caused by a blockage or by bleeding in the brain) more than 3 months ago.

Who may not be able to join:

Healthy participants:

  • People with a medical condition affecting the respiratory, cardiovascular, or metabolic systems, or any other condition that could affect the test.
  • People who have experienced pain in any part of the body lasting more than 1 week, at any point in the 3 months before the trial.

Post-stroke participants:

  • People who are unable to be transferred or to pedal actively during the test.
  • People for whom cardiovascular exercise is medically inadvisable for any reason.
  • People who are unable to follow instructions or describe physical sensations during the training.
  • People with another neurological condition, certain heart conditions (such as unstable angina, irregular heart rhythms, or problems with the aorta, left ventricle, heart muscle, or outer lining of the heart), certain lung conditions (such as pulmonary embolism or pulmonary hypertension), kidney or metabolic problems (such as severe kidney dysfunction or uncontrolled diabetes), an active infection or fever, or who have had brain surgery within 6 weeks before joining the study.
  • People who have experienced pain in any part of the body lasting more than 1 week, at any point in the 3 months before the trial.
  • People taking beta-blockers, antidepressants, or any other medication that may affect heart rate measurements.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alejandro Herrera Rojas, Physical Therapist, Neuron, Spain

Phone: + 34 640944777

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Neuron, Spain
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 September 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Pressure pain thresholds; Conditioned pain modulation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov